AGX

SEC source: 0001104659-19-075966 · a4.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (a) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (b) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (c) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (d) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (e) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027;

F3 · balance_after: (f) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (g) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028; and (h) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and an Expiration Date of 12/23/2029.

SEC source: 0001104659-19-075964 · a4.xml · derivative · entry 4

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (d) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable on 12/12/2019 and Expiration Date of 12/12/2028; and (e) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable beginning on 12/23/2020 and Expiration Date of 12/23/2029.

SEC source: 0001104659-19-075962 · a4.xml · derivative · entry 1

Koilpillai Mano S · CIK 0001790160 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2029-12-23

F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $42.31 per share with Date Exercisable beginning on 9/10/2020 and Expiration Date of 9/10/2029; and (b) options to acquire 10,000 shares of common stock at a price of $40.15 per share with Date Exercisable beginning on 12/23/2020 and Expiration Date of 12/23/2029.

SEC source: 0001104659-19-073479 · a4.xml · nonDerivative · entry 1

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,570

SEC source: 0001104659-19-073480 · a4.xml · nonDerivative · entry 1

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,700

SEC source: 0001104659-18-072876 · a4.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 10,000 shares

Expires 2028-12-12

F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share.

F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026;

F3 · balance_after: (v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (vi) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (vii) 10,000 shares of common stock at a purchase price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.

SEC source: 0001104659-19-055557 · a4.xml · nonDerivative · entry 1

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750

F1 · balance_after: On October 21, 2019, the Reporting Person purchased 750 shares of the Company's common stock on the open market at a price of $39.25 per share.

SEC source: 0001104659-19-024087 · a4.xml · nonDerivative · entry 3

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,333

F4 · shares: On April 26, 2019, the Reporting Person sold 17,212 shares of the Issuer's common stock on the open market at an average price of $49.27 per share.

SEC source: 0001104659-19-024087 · a4.xml · nonDerivative · entry 2

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,545

F3 · shares: On April 25, 2019, the Reporting Person sold 7,788 shares of the Issuer's common stock on the open market at an average price of $49.73 per share.

SEC source: 0001104659-19-024087 · a4.xml · derivative · entry 5

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,667

Underlying: Common Stock · 53,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2 · derivative.exercise_price: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

F1 · shares: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2 · shares: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

F1 · derivative.exercise_date: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2 · derivative.exercise_date: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

F1 · derivative.expiration_date: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2 · derivative.expiration_date: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

F1 · derivative.underlying_shares: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2 · derivative.underlying_shares: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

F5 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (i) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (ii) 6,667 shares of common stock at a price of $46.35 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (iii) options to acquire shares of common stock at a price of $41.19 per share, subject to a three-year ratably vesting schedule, with initial Date Exercisable beginning on 12/12/2019 and Expiration date of 12/12/2028.

SEC source: 0001104659-19-024087 · a4.xml · nonDerivative · entry 1

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On April 24, 2019, the Reporting Person exercised his stock option to purchase (i) 5,000 shares of the Issuer's common stock at a price of $12.43 per share with a Date Exercisable 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of the Issuer's common stock at a price of $17.33 with a Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of the Issuer's common stock at a price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of the Issuer's common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration date of 12/17/2023;

F2 · shares: (v) 10,000 shares of the Issuer's common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (vi) 10,000 shares of the Issuer's common stock at a price of $30.44 per share with Date Exercisable 1/7/2017 and Expiration Date of 1/7/2026; and (vii) 3,333 shares of the Issuer's common stock at a price of $46.35 per share Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. The average exercise price per share of the Issuer's common stock was $25.94.

SEC source: 0001104659-19-021575 · a4.xml · derivative · entry 3

BOSSELMANN RAINER H · CIK 0001028546 · Director · Chairman of the Board & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F5 · shares: On April 12, 2019, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2019 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F6 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 5 above.

F6 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 5 above.

F7 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 10,000 shares of PBRSUs granted on April 13, 2018, to vest in their entirety at the end of a three-year performance period; and (b) a target number of 10,000 shares of PBRSUs granted on April 12, 2019, to vest in their entirety at the end of a three-year performance period as reported under footnote 5 above.

SEC source: 0001104659-19-021575 · a4.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Director · Chairman of the Board & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,000

Underlying: Common Stock · 40,000 shares

Expires 2029-04-12

F2 · shares: On April 12, 2019, the Reporting Person received 10-year options to purchase 40,000 shares of the Issuer's common stock with an exercise price of $ 50.30 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/12/2020.

F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 25,000 shares of common stock at a price of $16.37 per share with Date Exercisable of 03/07/2014 and Expiration Date of 03/07/2023; (b) options to acquire 50,000 shares of common stock at a price of $32.68 with Date Exercisable of 04/16/2016 and Expiration Date of 04/16/2025; (c) options to acquire 50,000 shares of common stock at a price of $33.85 per share with Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (d) options to acquire 50,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; and (e) options to acquire 40,000 shares of common stock at a price of $37.60 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028.

F4 · balance_after: Options to acquire 40,000 shares of common stock at a price of $50.30 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029.

SEC source: 0001104659-19-021521 · a4.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F3 · shares: On April 12, 2019, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 8,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2019 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F4 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above.

F4 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above.

F5 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 13, 2018, to vest in their entirety at the end of a three-year performance period; and (b) a target number of 8,000 shares of PBRSUs granted on April 12, 2019, to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above.

SEC source: 0001104659-19-021521 · a4.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,000

Underlying: Common Stock · 32,000 shares

Expires 2029-04-12

F1 · shares: On April 12, 2019, the Reporting Person received 10-year options to purchase 32,000 shares of the Issuer's common stock with an exercise price of $50.30 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/12/2020.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; and (d) options to acquire 32,000 shares of common stock at a price of $50.30 subject to the aforementioned three-year ratably vesting schedule with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029.

SEC source: 0001104659-19-021519 · a4.xml · derivative · entry 1

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 10,000 shares

Expires 2029-04-12

F1 · shares: On April 12, 2019, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $50.30 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/12/2020.

F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; and (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029.

SEC source: 0001104659-18-072877 · a4.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,000

Underlying: Common Stock · 10,000 shares

Expires 2028-12-12

F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026;

F3 · balance_after: (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (f) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.

SEC source: 0001104659-18-073087 · a4.xml · derivative · entry 2

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 10,000 shares

Expires 2028-12-12

F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (i) 5,000 shares of Common Stock at an Exercise Price of $12.43 per share with Date Exercisable of 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (v) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024;

F3 · balance_after: (vi) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (vii) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (viii) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (ix) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.

SEC source: 0001104659-18-073086 · a4.xml · derivative · entry 2

QUINN JAMES E · CIK 0001016754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 10,000 shares

Expires 2028-12-12

F1 · shares: On December 12, 2018 (the "Grant Date") , the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $26.88 with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and

F3 · balance_after: (f) options to acquire10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.

SEC source: 0001104659-18-073085 · a4.xml · derivative · entry 4

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; (c) 10,000 shares of common stock at a price of $46 35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (d) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.

SEC source: 0001104659-18-073084 · a4.xml · derivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires 2028-12-12

F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; (b) 10,000 shares of common stock at a price of $46 35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (c) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028.

SEC source: 0001104659-18-048739 · a4.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 6,000

SEC source: 0001104659-18-024301 · a4.xml · derivative · entry 1

Deily Richard H · CIK 0001358787 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires 2028-04-13

F1 · shares: On April 13, 2018, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $37.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/13/2019.

F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; and (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028.

SEC source: 0001104659-18-024300 · a4.xml · derivative · entry 3

BOSSELMANN RAINER H · CIK 0001028546 · Director · Chairman of the Board & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F4 · shares: On April 13, 2018, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 10,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F5 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

F5 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 4 above.

SEC source: 0001104659-18-024300 · a4.xml · derivative · entry 2

BOSSELMANN RAINER H · CIK 0001028546 · Director · Chairman of the Board & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,000

Underlying: Common Stock · 40,000 shares

Expires 2028-04-13

F2 · shares: On April 13, 2018, the Reporting Person received 10-year options to purchase 40,000 shares of the Issuer's common stock with an exercise price of $37.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/13/2019.

F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 25,000 shares of common stock at a price of $16.37 per share with Date Exercisable of 03/07/2014 and Expiration Date of 03/07/2023; (b) options to acquire 50,000 shares of common stock at a price of $32.68 with Date Exercisable of 04/16/2016 and Expiration Date of 04/16/2025; (c) options to acquire 50,000 shares of common stock at a price of $33.85 per share with Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (d) options to acquire 50,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; and (e) options to acquire 40,000 shares of common stock at a price of $37.60 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028.

SEC source: 0001104659-18-024299 · a4.xml · derivative · entry 3

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F3 · shares: On April 13, 2018, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 8,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR.

F4 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above.

F4 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above.

SEC source: 0001104659-18-024299 · a4.xml · derivative · entry 2

Watson David Hibbert · CIK 0001482442 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,000

Underlying: Common Stock · 32,000 shares

Expires 2028-04-13

F1 · shares: On April 13, 2018, the Reporting Person received 10-year options to purchase 32,000 shares of the Issuer's common stock with an exercise price of $37.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/13/2019.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; and (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028.

SEC source: 0001104659-18-002134 · a4.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share.

F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (vi) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028.

SEC source: 0001104659-18-002083 · a4.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028.

SEC source: 0001104659-18-002082 · a4.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $ 26.88 with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028.

SEC source: 0001104659-18-002077 · a4.xml · derivative · entry 2

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $60.05 per share with Date Exercisable of 06/22/2018 and Expiration Date of 06/22/2027; and (b) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028.

SEC source: 0001104659-18-002380 · a4.xml · derivative · entry 4

Getsinger Peter W · CIK 0001627519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $30.44 per share with the date exercisable of 01/07/2017 and expiration date of 01/07/2026; (b) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 01/05/2018 and Expiration Date of 01/05/2027; and (c) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028.

SEC source: 0001104659-18-002379 · a4.xml · derivative · entry 2

MITCHELL W G CHAMPION · CIK 0001204823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 10,000 shares

Expires 2028-01-11

F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share.

F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (i) 5,000 shares of Common Stock at an Exercise Price of $12.43 per share with Date Exercisable of 12/17/2010 and Expiration Date of 12/17/2019; (ii) 5,000 shares of Common Stock at an Exercise Price of $17.33 per share with Date Exercisable of 12/20/2012 and Expiration Date of 12/20/2021; (iii) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (iv) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (v) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024;

F3 · balance_after: (vi) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (vii) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (viii) 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028.

SEC source: 0001104659-17-075428 · a4.xml · derivative · entry 2

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,000

Underlying: Common Stock · 3,000 shares

Expires 2023-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 27, 2017, the Reporting Person exercised her stock option to purchase 3,000 shares of the Issuer's common stock at a price of $26.88 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027.

SEC source: 0001104659-17-075428 · a4.xml · nonDerivative · entry 1

Flanders Cynthia · CIK 0001463638 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 27, 2017, the Reporting Person exercised her stock option to purchase 3,000 shares of the Issuer's common stock at a price of $26.88 per share.

SEC source: 0001104659-17-073151 · a4.xml · derivative · entry 4

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 5,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 12, 2017, the Reporting Person exercised his stock option to purchase 5,000 shares of the Issuer's common stock at a price of $17.33 per share

F2 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire (i) 10,000 shares of Common Stock at an Exercise Price of $18.87 per share with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022; (ii) 10,000 shares of Common Stock at an Exercise Price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (iii) 10,000 shares of Common Stock at an Exercise Price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (iv) 10,000 shares of Common Stock at an Exercise Price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (v) 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027.

SEC source: 0001104659-17-073151 · a4.xml · nonDerivative · entry 1

Leimkuhler William F. · CIK 0001361943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 12, 2017, the Reporting Person exercised his stock option to purchase 5,000 shares of the Issuer's common stock at a price of $17.33 per share

SEC source: 0001104659-17-072734 · a4.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 4,500

F1 · shares: On December 11, 2017, the Reporting Person purchased a total of 1,000 shares of the Issuer's common stock through his IRA account on the open market at a price of $47.60 per share.

SEC source: 0001104659-17-072735 · a4.xml · derivative · entry 2

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 10,000 shares

Expires 2022-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.underlying_shares: On December 8, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share.

F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $ 26.88 with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 per share with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027.

SEC source: 0001104659-17-072735 · a4.xml · nonDerivative · entry 1

QUINN JAMES W · CIK 0001094454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On December 8, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $18.87 per share.

SEC source: 0001104659-17-063764 · a4.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 3,500

F1 · shares: On October 20, 2017, the Reporting Person purchased a total of 1,000 shares of the Issuer's common stock through his IRA account on the open market at a price of $68.02 per share.

SEC source: 0001104659-17-058149 · a4.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 2,500

F1 · shares: On September 19, 2017, the Reporting Person purchased a total of 1,500 shares of the Issuer's common stock through his IRA account on the open market at a price of $62.49 per share.

SEC source: 0001104659-17-041525 · a4.xml · nonDerivative · entry 1

Jeffrey John Ronald Jr. · CIK 0001709914 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · John R. Jeffrey, IRA

Disclosed balance after: 1,000

F1 · shares: On June 26, 2017, the Reporting Person purchased a total of 1,000 shares of the Issuer's common stock through his IRA account on the open market at a price of $60.95 per share.

SEC source: 0001104659-17-039257 · a4.xml · nonDerivative · entry 1

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · shares: On June 12, 2017, the Reporting Person sold a total of 30,000 shares of the Issuer's Common Stock on the open market at an average price of $62.2396 per share.

SEC source: 0001104659-17-035269 · a4.xml · derivative · entry 6

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2026-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On May 24, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share.

F4 · balance_after: The total number of stock options owned by the Reporting Person includes options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027.

SEC source: 0001104659-17-035269 · a4.xml · derivative · entry 5

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 10,000 shares

Expires 2024-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On May 24, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $31.82 per share.

SEC source: 0001104659-17-035269 · a4.xml · derivative · entry 4

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 10,000 shares

Expires 2023-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 24, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $26.88 per share.

SEC source: 0001104659-17-035269 · a4.xml · nonDerivative · entry 3

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On May 24, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $30.44 per share.

SEC source: 0001104659-17-035269 · a4.xml · nonDerivative · entry 2

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On May 24, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $31.82 per share.

SEC source: 0001104659-17-035269 · a4.xml · nonDerivative · entry 1

CRUMPTON HENRY A · CIK 0001430958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 24, 2017, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's common stock at a price of $26.88 per share.